Lingyan Chen

508 total citations
16 papers, 375 citations indexed

About

Lingyan Chen is a scholar working on Surgery, Molecular Biology and Oncology. According to data from OpenAlex, Lingyan Chen has authored 16 papers receiving a total of 375 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Surgery, 6 papers in Molecular Biology and 3 papers in Oncology. Recurrent topics in Lingyan Chen's work include Cholesterol and Lipid Metabolism (7 papers), Peroxisome Proliferator-Activated Receptors (4 papers) and Drug Transport and Resistance Mechanisms (2 papers). Lingyan Chen is often cited by papers focused on Cholesterol and Lipid Metabolism (7 papers), Peroxisome Proliferator-Activated Receptors (4 papers) and Drug Transport and Resistance Mechanisms (2 papers). Lingyan Chen collaborates with scholars based in China, Canada and New Zealand. Lingyan Chen's co-authors include Chao‐Ke Tang, Zhen-Wang Zhao, Duo Gong, Xi‐Long Zheng, Xiao-Dan Xia, Xingkun Zeng, Shanshan Shen, Jing Yan, Min Zhang and Guo-Jun Zhao and has published in prestigious journals such as SHILAP Revista de lepidopterología, Biochemical and Biophysical Research Communications and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Lingyan Chen

15 papers receiving 373 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lingyan Chen China 11 145 144 95 64 63 16 375
Jiamei Lu China 13 264 1.8× 69 0.5× 45 0.5× 68 1.1× 89 1.4× 24 542
Qiaoyan Guo China 12 195 1.3× 41 0.3× 36 0.4× 34 0.5× 48 0.8× 33 495
Fuzhe Ma China 13 212 1.5× 33 0.2× 110 1.2× 30 0.5× 42 0.7× 25 426
Diego Scerbo United States 9 196 1.4× 77 0.5× 46 0.5× 70 1.1× 33 0.5× 11 392
Ying‐Le Xu China 11 129 0.9× 114 0.8× 41 0.4× 37 0.6× 25 0.4× 15 426
Yichen Jia China 10 160 1.1× 75 0.5× 38 0.4× 25 0.4× 45 0.7× 15 350
Hanying Xing China 13 204 1.4× 31 0.2× 155 1.6× 45 0.7× 34 0.5× 19 406
Wolin Hou China 9 200 1.4× 106 0.7× 24 0.3× 38 0.6× 59 0.9× 11 446
Özge Telci Çaklılı Türkiye 9 91 0.6× 63 0.4× 72 0.8× 104 1.6× 21 0.3× 39 398
Hye Jin Wang South Korea 11 161 1.1× 146 1.0× 56 0.6× 52 0.8× 32 0.5× 14 503

Countries citing papers authored by Lingyan Chen

Since Specialization
Citations

This map shows the geographic impact of Lingyan Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lingyan Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lingyan Chen more than expected).

Fields of papers citing papers by Lingyan Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lingyan Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lingyan Chen. The network helps show where Lingyan Chen may publish in the future.

Co-authorship network of co-authors of Lingyan Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Lingyan Chen. A scholar is included among the top collaborators of Lingyan Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lingyan Chen. Lingyan Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Zhu, Mengdi, Fengxia Li, Shuting Huang, et al.. (2025). Plasma concentration of cyclic glycine proline is associated with impaired energy metabolism in a Chinese population of type 2 diabetes mellitus. SHILAP Revista de lepidopterología. 17. 100219–100219.
2.
Chen, Lingyan, et al.. (2025). Associations of Blood Pressure Variability, Heart Rate, and Target Organ Damage in Resistant Hypertension Patients. Journal of Clinical Hypertension. 27(6). e70081–e70081. 1 indexed citations
3.
Chen, Lingyan. (2024). A Current Clinical Overview of Atrophic Gastritis. 5(1). 1 indexed citations
4.
Chen, Lingyan, et al.. (2023). Ultrasound-guided acupotomy for trigger finger: a systematic review and meta-analysis. Journal of Orthopaedic Surgery and Research. 18(1). 678–678. 6 indexed citations
5.
Zhang, Guofeng, et al.. (2022). Ligustrazine Attenuates Liver Fibrosis by Targeting miR-145 Mediated Transforming Growth Factor-β/Smad Signaling in an Animal Model of Biliary Atresia. Journal of Pharmacology and Experimental Therapeutics. 381(3). 257–265. 14 indexed citations
6.
Chen, Lingyan, Jiayu Wu, Weiying Ren, et al.. (2022). The Relationship between Skeletal Muscle Mass and Bone Mass at Different Sites in Older Adults. Annals of Nutrition and Metabolism. 79(2). 256–262. 6 indexed citations
7.
Chen, Lingyan, et al.. (2022). 6-Shogaol alleviates CCl4-induced liver fibrosis by attenuating inflammatory response in mice through the NF-κB pathway. Acta Biochimica Polonica. 69(2). 363–370. 11 indexed citations
8.
Xia, Xiao-Dan, Xiao-Hua Yu, Lingyan Chen, et al.. (2020). Myocardin suppression increases lipid retention and atherosclerosis via downregulation of ABCA1 in vascular smooth muscle cells. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1866(4). 158824–158824. 16 indexed citations
9.
Dai, Lili, et al.. (2020). Resveratrol inhibits ACHN cells via regulation of histone acetylation. Pharmaceutical Biology. 58(1). 231–238. 11 indexed citations
10.
Yan, Jing, et al.. (2019). Relationship between nutritional status and frailty in hospitalized older patients. Clinical Interventions in Aging. Volume 14. 105–111. 61 indexed citations
11.
Tan, Yu-lin, Duo Gong, Zhen-Wang Zhao, et al.. (2019). Tanshinone IIA Promotes Macrophage Cholesterol Efflux and Attenuates Atherosclerosis of apoE-/- Mice by Omentin-1/ABCA1 Pathway. Current Pharmaceutical Biotechnology. 20(5). 422–432. 26 indexed citations
12.
Zhang, Min, Guo-Jun Zhao, Feng Yao, et al.. (2018). AIBP reduces atherosclerosis by promoting reverse cholesterol transport and ameliorating inflammation in apoE −/− mice. Atherosclerosis. 273. 122–130. 38 indexed citations
13.
Zhao, Zhen-Wang, Min Zhang, Lingyan Chen, et al.. (2018). Heat shock protein 70 accelerates atherosclerosis by downregulating the expression of ABCA1 and ABCG1 through the JNK/Elk-1 pathway. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1863(8). 806–822. 48 indexed citations
14.
Zhang, Min, Guo-Jun Zhao, Kai Yin, et al.. (2018). Apolipoprotein A-1 Binding Protein Inhibits Inflammatory Signaling Pathways by Binding to Apolipoprotein A-1 in THP-1 Macrophages. Circulation Journal. 82(5). 1396–1404. 40 indexed citations
15.
Li, Conghui, Duo Gong, Lingyan Chen, et al.. (2017). Puerarin promotes ABCA1-mediated cholesterol efflux and decreases cellular lipid accumulation in THP-1 macrophages. European Journal of Pharmacology. 811. 74–86. 52 indexed citations
16.
Gong, Duo, Haipeng Cheng, Wei Xie, et al.. (2016). Cystathionine γ-lyase(CSE)/hydrogen sulfide system is regulated by miR-216a and influences cholesterol efflux in macrophages via the PI3K/AKT/ABCA1 pathway. Biochemical and Biophysical Research Communications. 470(1). 107–116. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026